Intelligent Medicine®

ENCORE: DNA testing: Is it ready for Prime-Time? Part 1

Dr. Sharon Hausman-Cohen, Chief Medical Director of IntellxxDNA, shares her perspective on the genetic testing revolution. What’s the difference between a mutation and a SNP (single nucleotide polymorphism)? How does the IntellxxDNA test differ from, say, 23andMe? Isn’t it potentially scary to find out you have a “bad” gene, like the ApoE4 gene that’s associated with Alzheimer’s Disease risk? Can genetic risk factors be overcome with diet, exercise, and targeted supplements? IntellxxDNA pinpoints obesity genes, genes that predispose to diabetes and heart disease, macular degeneration, autoimmune disorders, thyroid problems and osteoporosis. Certain SNPs predict the likelihood of neurodegenerative diseases when exposed to environmental toxins like mercury and glyphosate. Others may dictate higher requirements for antioxidants, B vitamins, magnesium, vitamin D, and choline. Why is the IntellxxDNA test only available through health practitioners? Some critics say genetic testing is only in its infancy and not yet ready for primetime—is this mistaken? What can genomic testing tell us about remedial strategies for autism? Click HERE for part 2.

You may also like...

Featured Article
Latest Podcast
Featured Product

Do you wish you could turn back the clock on aging?

NTFactor® Lipids have been shown to repair mitochondrial damage, a primary cause of biological aging. They’ve also been shown to reduce fatigue by more than 40% and improve the quality of life in patients with various conditions, like chronic fatigue or those undergoing chemotherapy.

Right now, you can save big with their Essentials Bundle! It includes either size of their NTFactor® Lipids powder at a special 20% discount, plus a FREE bottle of Patented Energy wafers!

 

Learn more